Synthesis and characterization of a triphenylphosphonium-conjugated peroxidase mimetic. Insights into the interaction of ebselen with mitochondria.
about
Inhibition of Schistosoma mansoni thioredoxin-glutathione reductase by auranofin: structural and kinetic aspectsMitochondria-Targeted Antioxidants: Future Perspectives in Kidney Ischemia Reperfusion InjuryTargeting Mitochondria and Reactive Oxygen Species-Driven Pathogenesis in Diabetic NephropathyMitochondria as a target in treatmentMitochondrial-targeted fluorescent probes for reactive oxygen species.Targeted delivery of radioprotective agents to mitochondriaMitochondrial oxidative stress and mammalian healthspan.Bench-to-bedside review: Targeting antioxidants to mitochondria in sepsis.Design and Synthesis of a Mitochondria-Targeted Mimic of Glutathione Peroxidase, MitoEbselen-2, as a Radiation Mitigator.Molecular strategies for targeting antioxidants to mitochondria: therapeutic implications.Regulation of VEGF-induced endothelial cell migration by mitochondrial reactive oxygen speciesTargeted nanoparticles in mitochondrial medicine.Strategies for reducing or preventing the generation of oxidative stressLipophilic triphenylphosphonium cations inhibit mitochondrial electron transport chain and induce mitochondrial proton leak.Mitochondrial medicine: pharmacological targeting of mitochondria in diseaseDelivery of drugs and macromolecules to mitochondria.Mitochondria: new drug targets for oxidative stress-induced diseases.Mitochondria-targeted antioxidants for treatment of Parkinson's disease: preclinical and clinical outcomes.Antioxidant approaches for the treatment of Alzheimer's disease.Metabolic manipulators: a well founded strategy to combat mitochondrial dysfunction.Mitochondrial protein tyrosine nitration.Controlling subcellular delivery to optimize therapeutic effectToxicology and pharmacology of selenium: emphasis on synthetic organoselenium compounds.The subcellular distribution of small molecules: from pharmacokinetics to synthetic biologyDelivery to mitochondria: a narrower approach for broader therapeutics.Perspectives and potential applications of mitochondria-targeted antioxidants in cardiometabolic diseases and type 2 diabetes.Tenofovir-induced nephrotoxicity: incidence, mechanism, risk factors, prognosis and proposed agents for prevention.Mitochondria-Targeted Antioxidants for the Treatment of Cardiovascular Disorders.Mitochondria and neurodegenerative diseases: the promising role of nanotechnology in targeted drug delivery.Accumulation of lipophilic dications by mitochondria and cells.Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic Applications.Role of Oxidative Stress and Mitochondrial Dysfunction in Sepsis and Potential Therapies.Molecular design of new inhibitors of peroxidase activity of cytochrome c/cardiolipin complexes: fluorescent oxadiazole-derivatized cardiolipinCorrection to "Design and Synthesis of a Mitochondria-Targeted Mimic of Glutathione Peroxidase, MitoEbselen-2, as a Radiation Mitigator"Mitochondrial targeting as a novel therapy for stroke
P2860
Q24652462-F7B68BAB-E90F-4B12-ADA5-479C14FF453DQ26744639-BC4D2206-4CDF-4546-9E58-998A66DB9DE2Q28083205-E5FE3A81-E8D5-4464-BA6D-5F7E3D483A97Q28382780-EE21DFB1-976F-49F2-A18A-8E1D289A34C4Q33698018-5D2A8A39-3FE8-413B-9725-7B08E196170AQ33972592-74320C12-CF9A-47A7-BC61-0356103DE8E7Q34104004-96511DFF-9FA8-4CC9-A797-5830B74A758FQ34153200-C84E731C-E8A9-4115-BB67-B6097E3BD6EEQ34701269-FA4E7193-857F-4717-BAC0-83B32065CAE3Q35148462-71DB8D7E-B51A-480A-9A55-54E7C0AFE4B4Q35216857-A66390A7-1E0A-4770-BC9D-9B621BA9E0DCQ35417165-E8452052-0CEF-427A-BE23-33EF2BF4BC9AQ35609538-A771D97C-0BE2-4AAA-8875-13484A9C4931Q35618767-239AB2A0-D00F-4189-AEBF-162C5BCC84A6Q36358060-4EA4C499-60C0-4161-B945-A8268412C1F5Q36495454-F63044B6-ABC3-4802-BEF9-30246EF9E986Q36545033-E28DC798-76E0-4ACB-9462-48A2B28774B7Q37653023-2B46BEFE-93D1-4242-8E01-EDCB1F73C290Q37768449-08823CD2-5742-4144-936E-F713340B93FDQ37776434-DBCBF72D-2BDA-4CF5-9BA2-2C8ED66E9F1EQ37799814-B4F832E1-2773-47E6-8800-FB9CB523A8ADQ37813021-EFDF8130-838F-4792-8DC8-EED725D962DDQ37896536-D8779624-8BCC-41C7-90CA-75349FFBADF7Q37909301-CF898B00-5337-4892-8D43-F12286BF3E3DQ38015903-7F272715-9780-43ED-98ED-6AC3C096E265Q38104693-FB45CE62-424E-485C-A54C-E0C1B60479AEQ38222708-4477F4ED-064D-4945-8E6E-7C5A6E1C8B94Q38678059-6E0DC32D-E13E-4BC1-A710-01A253D1A55BQ38910964-83BEC974-DF21-43E0-B878-59F7F8FBD72DQ39086210-FE63C570-00CB-492F-88D3-ED65E6D028E0Q39400621-8EC86C41-8FA8-4694-88DD-C02040326468Q41622494-9026B5C8-8907-47F2-B704-EDA290ED809AQ41811797-3FA46B76-FE7B-49AA-B7B4-37ED89AACFCFQ42700210-27FBDC1B-9424-42E4-9433-D95D5C9436B7Q59132572-4234184E-02DD-47E1-B00B-57F1B7BDEF7D
P2860
Synthesis and characterization of a triphenylphosphonium-conjugated peroxidase mimetic. Insights into the interaction of ebselen with mitochondria.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Synthesis and characterization ...... of ebselen with mitochondria.
@en
Synthesis and characterization ...... of ebselen with mitochondria.
@nl
type
label
Synthesis and characterization ...... of ebselen with mitochondria.
@en
Synthesis and characterization ...... of ebselen with mitochondria.
@nl
prefLabel
Synthesis and characterization ...... of ebselen with mitochondria.
@en
Synthesis and characterization ...... of ebselen with mitochondria.
@nl
P2093
P2860
P356
P1476
Synthesis and characterization ...... n of ebselen with mitochondria
@en
P2093
Geoffrey F Kelso
Robin A J Smith
Samantha M Beer
Stephanie E Brown
P2860
P304
24113-24126
P356
10.1074/JBC.M501148200
P407
P577
2005-04-14T00:00:00Z